Tanshinone IIA attenuates H2O2-induced injury in human umbilical vein endothelial cells

American Journal of Chinese Medicine

Volumn 40, Issue 6, 2012, Pages 1307-1319

  Chan, Paul ^a,d   Chen, Yen Cheng ^b,d   Lin, Li Jen ^c   Cheng, Tzu Hurng ^c   Anzai, Kazunori ^f   Chen, Yin Han ^e   Liu, Zhong Min ^e   Lin, Jaung Geng ^c   Hong, Hong Jye ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d St Mary's Hospital   (Taiwan)

^e TONGJI UNIVERSITY   (China)

^f NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Activating Transcription Factor 3; Apoptosis; Endothelial Cells; Hydrogen Peroxide; Tanshinone IIA; Traditional Chinese Medicine

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CASPASE 3; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PROTEIN P53; TANSHINONE IIA;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DITERPENES, ABIETANE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; HYDROGEN PEROXIDE; IN SITU NICK-END LABELING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UMBILICAL VEINS;

EID: 84871342616     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500966     Document Type: Article

References (28)

1. Bottone, F.G. Jr, Y. Moon, J.S. Kim, B. Alston-Mills, M. Ishibashi and T.E. Eling. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Mol. Cancer Ther. 4: 693-703, 2005.
2. Chan, P., J.C. Liu, L.J. Lin, P.Y. Chen, T.H. Cheng, J.G. Lin and H.J. Hong. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts. Am. J. Chin. Med. 39: 381-394, 2011.
3. Chao, H.H., C.H. Chen, J.C. Liu, J.W. Lin, K.L. Wong and T.H. Cheng. L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1- phosphate generation. J. Nutr. Biochem. 21: 580-588, 2010.
4. Chao, H.H., J.C. Liu, H.J. Hong, J.W. Lin, C.H. Chen and T.H. Cheng. L-carnitine reduces doxorubicin- induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes. Int. J. Cardiol. 146: 145-152, 2011.
5. Chen, B.P., C.D. Wolfgang and T. Hai. Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol. Cell. Biol. 16: 1157-1168, 1996.
6. Chen, S.C., Y.C. Liu, K.G. Shyu and D.L. Wang. Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 201: 281-288, 2008.
7. Cheng, T.O. Cardiovascular effects of Danshen. Int. J. Cardiol. 121: 9-22, 2007.
8. Cheng, T.O. Danshen: a popular Chinese cardiac herbal drug. J. Am. Coll.Cardiol. 47: 1498; author reply 1499-1500, 2006.
9. Dimmeler, S. and A.M. Zeiher. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87: 434-439, 2000.
10. Evan, G. and T. Littlewood. A matter of life and cell death. Science 281: 1317-1322, 1998.
11. Gilchrist, M., V. Thorsson, B. Li, A.G. Rust, M. Korb, J.C. Roach, K. Kennedy, T. Hai, H. Bolouri and A. Aderem. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441: 173-178, 2006.
12. Hai, T. and M.G. Hartman. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1-11, 2001.
13. Hai, T., C.D. Wolfgang, D.K. Marsee, A.E. Allen and U. Sivaprasad. ATF3 and stress responses. Gene Expr. 7: 321-335, 1999.
14. Hashimoto, Y., C. Zhang, J. Kawauchi, I. Imoto, M.T. Adachi, J. Inazawa, T. Amagasa, T. Hai and S. Kitajima. An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids Res. 30: 2398-2406, 2002.
15. Hong, H.J., F.L. Hsu, S.C. Tsai, C.H. Lin, J.C. Liu, J.J. Chen, T.H. Cheng and P. Chan. Tanshinone IIA attenuates cyclic strain-induced endothelin-1 expression in human umbilical vein endothelial cells. Clin. Exp. Pharmacol. Physiol. 39: 63-68, 2012.
16. Hong, H.J., J.C. Liu, P.Y. Chen, J.J. Chen, P. Chan and T.H. Cheng. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway. Int. J. Cardiol. 157: 174-179, 2010a.
17. Hong, H.J., J.C. Liu, T.H. Cheng and P. Chan. Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes. Acta Pharmacol. Sin. 31: 1569-1575, 2010b.
18. Kawauchi, J., C. Zhang, K. Nobori, Y. Hashimoto, M.T. Adachi, A. Noda, M. Sunamori and S. Kitajima. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through downregulation of p53 transcription. J. Biol. Chem. 277: 39025-39034, 2002.
19. Lin, R., W.R. Wang, J.T. Liu, G.D. Yang and C.J. Han. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J.Ethnopharmacol. 108: 217-222, 2006.
20. Liu, X., Y. Wang, C. Ma, L. Zhang, W. Wu, S. Guan, M. Yang, J. Wang, B. Jiang and D.A. Guo. Proteomic assessment of tanshinone IIA sodium sulfonate on doxorubicin induced nephropathy. Am. J. Chin. Med. 39: 395-409, 2011.
21. Mashima, T., S. Udagawa and T. Tsuruo. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J. Cell Physiol. 188: 352-358, 2001.
22. Papaharalambus, C.A. and K.K. Griendling. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc. Med. 17: 48-54, 2007.
23. Stridh, H., M. Kimland, D.P. Jones, S. Orrenius and M.B. Hampton. Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltin-induced apoptosis. FEBS Lett. 429: 351-355, 1998.
24. Tang, C., A.H. Wu, H.L. Xue and Y.J. Wang. Tanshinone IIA inhibits endothelin-1 production in TNF-alpha-induced brain microvascular endothelial cells through suppression of endothelinconverting enzyme-1 synthesis. Acta Pharmacol. Sin. 28: 1116-1122, 2007.
25. Tang, X., X. Yang, Y. Peng and J. Lin. Protective effects of lycopene against H2O2-induced oxidative injury and apoptosis in human endothelial cells. Cardiovasc. Drugs Ther. 23: 439-448, 2009.
26. Yin, Y., M. Yang, Y. Wang, X. Liu, W. Wu, S. Guan, D.A. Guo, Y. Cui and B. Jiang. Tanshinone IIA increases mRNA expression of efflux transporters in cultured human intestinal cell. Am. J. Chin. Med. 38: 995-1004, 2010.
27. Zhou, L., Z. Zuo and M.S. Chow. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45: 1345-1359, 2005.
28. Zimmermann, K.C. and M.J. Pinkoski. In the company of killers. Trends Mol. Med. 7: 195-197, 2001.